The Effect of A1 Adenosine Receptor in Diabetic Megalin Loss with Caspase-1/IL18 Signaling [Corrigendum]

The Effect of A1 Adenosine Receptor in Diabetic Megalin Loss with Caspase-1/IL18 Signaling [Corrigendum]

Tian D, Shi X, Zhao Y, et al. Diabet Metab Syndr Obes. 2019;12:1583– 1596.The authors of this paper have advised that Figures 5 and 6 are incorrect. The authors provided only one actin control for each treatment. However, their different target proteins had their own matched actin from the...

Full description

Bibliographic Details
Main Authors: Tian D, Shi X, Zhao Y, Peng X, Zou L, Xu L, Ma Y, Wen Y, Faulhaber-Walter R, Chen L
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
a1 adenosine receptor
diabetic nephropathy
caspase-1
megalin
Online Access:https://www.dovepress.com/250600-dmso-corrigendum-the-effect-of-a1-adenosine-receptor-in-diabeti-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/250600-dmso-corrigendum-the-effect-of-a1-adenosine-receptor-in-diabeti-peer-reviewed-article-DMSO

Similar Items